Arkolith/Insider Trading/PRME/Form 4

Nelsen Robert

Director, 10% OwnerPrime Medicine, Inc. (PRME) · full profile →Form 4 · filed Aug 5, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
0 non-derivative · 4 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 1, 2025Grant(A)45K——45K
Aug 1, 2025Disposed to issuer(D)39K——0
Aug 1, 2025Disposed to issuer(D)45K——0
Aug 1, 2025Grant(A)39K——39K

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001894562-25-000049) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML